Rothschild & CO Asset Management Us Inc. Bristol Myers Squibb CO Transaction History

Rothschild & CO Asset Management Us Inc.

$6.56 Billion
Q4 2022

A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 1,482,940 shares of BMY stock, worth $75.5 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

1,482,940

Previous 1,453,644 2.02%

Holding current value

$75.5 Million

Previous $103 Million 3.23%

% of portfolio

1.63%

Previous 1.77%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $2.01 Million - $2.38 Million	29,296 Added 2.02%	1,482,940 $107 Million
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $13,389 - $7.91 Million	-102,993 Reduced 6.62%	1,453,644 $103 Million
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $4.65 Million - $5.12 Million	-64,019 Reduced 3.95%	1,556,637 $120 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $2 Million - $2.4 Million	32,524 Added 2.05%	1,620,656 $118 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $484,332 - $564,618	-9,031 Reduced 0.57%	1,588,132 $99 Million
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $1.55 Million - $1.82 Million	-26,240 Reduced 1.62%	1,597,163 $94.5 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $3.66 Million - $3.99 Million	59,149 Added 3.78%	1,623,403 $108 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $14.8 Million - $16.7 Million	249,731 Added 19.0%	1,564,254 $98.8 Million
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $40.1 Million - $45.4 Million	694,428 Added 111.99%	1,314,523 $81.5 Million
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $35 Million - $38.8 Million	609,574 Added 5793.88%	620,095 $37.4 Million
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $86,181 - $102,180	2,015 Added 23.69%	10,521 $534,000
Q2 2019 Jul 25, 2019	BUY	$44.62 - $49.34 $51,669 - $57,135	1,158 Added 15.76%	8,506 $386,000
Q4 2018 Feb 05, 2019	SELL	$48.76 - $63.23 $40,031 - $51,911	-821 Reduced 10.05%	7,348 $382,000
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $89,892 - $112,041	1,779 Added 27.84%	8,169 $452,000
Q1 2018 May 08, 2018	BUY	$59.92 - $68.98 $21,211 - $24,418	354 Added 5.86%	6,390 $404,000
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $333,368 - $384,734	6,036	6,036 $385,000

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.

Account

Rothschild & CO Asset Management Us Inc. Bristol Myers Squibb CO Transaction History